Katie Thurston Shared Cancer Treatment Update
The television personality provided an update on her ongoing breast cancer treatment and upcoming medical scans.
Updated on Oct. 12, 2026 in Cancer
Katie Thurston, who was diagnosed with breast cancer in February 2025, has shared an update on her medical status following recent scan results. She is currently managing her condition with a regimen of ovary-suppressing injections and targeted inhibitor medications.
Why it matters
Understanding how different physical activities and treatments can influence diagnostic imaging results is a critical part of ongoing cancer care. Thurston shared these details as she navigates health complications, including elevated liver enzymes and previous cancer metastasis.
Thurston undergoes quarterly ovary-suppression injections alongside a daily regimen of aromatase and CDK4/6 inhibitors. Clinical monitoring involves PET scans to track inflammation and cancer activity, with an FES scan scheduled to provide further clarity.
The players
Katie Thurston
Katie Thurston is a television personality who gained prominence after appearing on the reality dating franchise The Bachelor.
The details
After learning that her cancer had spread to her liver in March 2025, Thurston underwent a double mastectomy in April 2026. A recent PET scan revealed increased light intensity on the right side of her body, though this may be linked to inflammation from exercise performed prior to the scan.
Timeline
Katie Thurston was diagnosed with breast cancer in February 2025.
The cancer was confirmed to have spread to her liver in March 2025.
Thurston underwent a double mastectomy in April 2026.
Thurston had a chin liposuction procedure in September 2026.
An FES scan is scheduled for October 13, 2026.
Health Landscape
The use of CDK4/6 inhibitors in metastatic breast cancer therapy has fundamentally altered treatment protocols for many patients. This story follows the standard clinical progression for patients managed with these inhibitors, marking a shift in how metastatic disease is treated.
The case highlights how exercise-induced inflammation can potentially complicate the interpretation of PET scan results, reminding patients to consult their doctors about pre-scan activity. It also emphasizes the importance of consistent medication adherence for those on complex hormone and CDK4/6 inhibitor regimens.
The takeaway
Patients navigating metastatic cancer treatment often face complex diagnostic hurdles where minor lifestyle factors can influence medical imaging. Maintaining clear communication with an oncology team about physical activity and side effects is essential for accurate health monitoring.
What happens next
Katie Thurston is scheduled to undergo an FES scan on October 13, 2026, and plans to share the results later in the month.
Further reading
Learn more about the latest developments in Cancer research and patient care.
Source note: This article includes information reported by Reality TV World.
